Carbinoxamine Maleate Extended-release Oral Suspension Suspension, Extended Release
Product Images NDC 62542-101

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbinoxamine Maleate Extended-release Oral Suspension (NDC 62542-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Neos Therapeutics, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbinoxamine Maleate Label (19654 Carbinoxamine Maleate Er Label 16 Oz. Tris Neos Lb8787 Rev. 00)

Label for Carbinoxamine Maleate Extended-Release Oral Suspension 4 mg/5 mL, a human prescription drug in extended-release suspension form. The 16 fl oz (480 mL) bottle is strawberry banana flavored and labeled for oral use, with instructions to shake well and dose every 12 hours. Manufactured by Tris Pharma, Inc. for Neos Therapeutics, LP. Includes barcode and storage instructions.*

FDA Label Image

Neos Logo (New Logo)

FDA Label Image

Structure 1 (Structure 1)

Chemical structure diagram of Carbinoxamine Maleate, showing its molecular configuration with labeled atoms and bonds.*

FDA Label Image

Structure 2 (Structure 2)

Chemical structure diagram of Carbinoxamine Maleate illustrating the molecular arrangement with labeled functional groups and atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.